UK Pharmacies Recommending Short-Term Treatments Over PPIs For Frequent Heartburn – Haleon Survey
Executive Summary
Haleon data shows a notable increase in UK pharmacy teams recommending PPIs for frequent heartburn in the year ended September 2022. However, pharmacies are still recommending alginate-based OTCs and antacids over PPIs for frequent heartburn in the majority of occasions, which Haleon says points to a need for more pharmacy education.
You may also be interested in...
Haleon's UK Nexium Extension Sates Appetite For Larger Pack Size
The launch of a larger pack size for Nexium Control offers frequent heartburn sufferers “improved value at a lower cost per tablet, and a second course of medication on hand should their symptoms reoccur at a later date,” says Haleon.
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
‘Meaningful Revenues’ In 2023 Mark Strategic Milestone As Futura Looks To Future
Futura recorded its first notable revenues last year, generated by the launch of its Eroxon erectile dysfunction gel in the UK and Europe, marking the company's transition from an R&D startup to a consumer healthcare player in its own right. To mark the occasion, CEO James Barder outlines a new strategy, with a focus on innovation in sexual wellness, further global partnerships and sustained profitability.